Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer

The objective of the present registry is the creation of a prospective registry collecting clinico-pathological and genomic data, along with survival outcomes, of individuals diagnosed with PDAC at or before the age of 55 years old. This registry is intended with the aim of using collected data for future clinical trials, both prospective and retrospective.

NCT Number	NCT05845801
Lead Sponsor	Azienda Ospedaliera Universitaria Integrata Verona
Conditions	PDAC - Pancreatic Ductal Adenocarcinoma
Enrollment	3,000 participants
Start Date	2022-12-07
Primary Completion	2052-09-30 (estimated)
Study Completion	2052-09-30 (estimated)
Updated on ClinicalTrials.gov	2023-05-06